EnsoData Raises $20M Series B to Boost AI Sleep Solutions
Deal News | Jun 25, 2025 | Questa Capital Management LLC
EnsoData, a company specializing in AI-driven sleep medicine solutions, has successfully raised $20 million in a Series B funding round. The financing was led by Questa Capital, with notable participation from Zetta Venture Partners and Venture Investors Health Fund. The primary aim of this funding is to hasten the adoption of EnsoData’s FDA-cleared AI platform, which covers the entire sleep care spectrum from diagnosis to therapy. An estimated 80% of sleep apnea patients are undiagnosed, and only half of those diagnosed receive effective treatment, a significant healthcare challenge EnsoData seeks to address. With plans to expand its influence into adjacent medical fields, the company has also made significant commercial expansions, highlighted by the recent appointment of Bobby Cockrill as Chief Commercial Officer. EnsoData intends to significantly bolster its US sales team to augment the deployment of its AI solutions, which have assisted over 2.5 million patients to date.
Sectors
- Healthcare Technology
- Artificial Intelligence
- Investment
Geography
- United States – EnsoData is scaling its commercial operations within the US, and the funding targets healthcare challenges faced by millions of Americans.
Industry
- Healthcare Technology – The article is focused on EnsoData's technology-based healthcare solutions for sleep medicine, emphasizing AI and machine learning.
- Artificial Intelligence – EnsoData's platform leverages AI and machine learning to enhance the diagnosis and treatment of sleep disorders.
- Investment – The article discusses a funding round led by Questa Capital for EnsoData, involving capital investment in healthcare innovation.
Financials
- 20,000,000 – The amount raised by EnsoData in its Series B funding led by Questa Capital.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| EnsoData | Target | Company | Provides AI-powered sleep medicine solutions and raised $20 million in Series B financing. |
| Questa Capital Management LLC | Bidding Company/Investor | Company | Led the $20 million Series B funding round for EnsoData. |
| Zetta Venture Partners | Investor | Company | Participated as an existing investor in EnsoData's Series B funding round. |
| Venture Investors Health Fund | Investor | Company | Participated as an existing investor in EnsoData's Series B funding round. |
| Bobby Cockrill | Chief Commercial Officer | Person | The newly appointed Chief Commercial Officer of EnsoData tasked with leading commercial expansion. |